The spread of klebsiella pneumoniae carbapenemases: A tale of strains, plasmids, and transposons

Clinical Infectious Diseases

Volumn 49, Issue 11, 2009, Pages 1739-1741

  Munoz Price, L Silvia ^a,b   Quinn, John P ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBAPENEM; CARBAPENEMASE; CEPHALOSPORIN; COLISTIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TIGECYCLINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; DISEASE TRANSMISSION; ENTEROBACTERIACEAE; GENE MUTATION; GENE TRANSFER; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MOLECULAR TYPING; NEPHROTOXICITY; NONHUMAN; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENE TRANSFER, HORIZONTAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PLASMIDS; POLYMERASE CHAIN REACTION; SERRATIA MARCESCENS;

EID: 72849118806     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/648078     Document Type: Note

References (19)

1. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20:440-458
2. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-36
3. Landman D, Bratu S, Kochar S, et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother 2007; 60:78-82.
4. Kitchel B, Rasheed JK, Patel JB, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009; 53: 3365-q70
5. Naas T, Nordmann P, Vedel G, Poyart C. Plasmid- mediated carbapenem-hydrolyzing betalactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 2005; 49:4423-4424
6. Navon-Venezia S, Leavitt A, Schwaber MJ, et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009; 53:818-820
7. Lahey Clinic Web site. Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant β-lactamases. Available at: http://www.lahey.org/studies. Accessed 15 Oct 2009.
8. Gootz TD, Lescoe MK, Dib-Hajj F, et al. Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob Agents Chemother 2009; 53:1998-2004.
9. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrob Agents Chemother 2008; 52:1257-1263
10. Moland ES, Hong SG, Thomson KS, Larone DH, Hanson ND. Klebsiella pneumoniae isolate producing at least eight different betalactamases, including AmpC and KPC betalactamases. Antimicrob Agents Chemother 2007; 51:800-801
11. Sidjabat HE, Silveira FP, Potoski BA, et al. Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient. Clin Infect Dis 2009; 49:1736-1738 (in this issue).
12. Bennett JW, Herrera ML, Lewis JS, Wickes BW, Jorgensen JH. KPC-2-producing Enterobacter cloacae and Pseudomonas putida coinfection in a liver transplant recipient. Antimicrob Agents Chemother 2009; 53:292-294
13. Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob Agents Chemother 2008; 52:3725-3736
14. Anthony KB, Fishman NO, LinkinDR, Gasink LB, Edelstein PH, Lautenbach E. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis 2008; 46:567-570
15. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006; 10:R27.
16. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29: 1099-1106
17. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009; 30:447-452
18. Won S, Munoz-Price LS, Lolans K, et al. Multi-facility emergence and rapid spread of KPC+ Enterobacteriaceae in Northwest Indiana (NWI) and Illinois (IL) 224 [abstract: 67]. In: Programs and abstracts of the 19th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (San Diego). Arlington, VA: Society for Healthcare Epidemiology of America, 2009.
19. Srinivasan A, Patel JB. Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure. Infect Control Hosp Epidemiol 2008; 29:1107-1109